The purpose of this workshop is to contribute to the knowledge of clinically qualified medical physicists in nuclear medicine by providing theoretical and practical tools for internal dosimetry. Molecular radiotherapy has demonstrated unique therapeutic advantages in the treatment of an increasing number of cancer types. Such treatments can deliver high absorbed doses to specific targets (tumour lesions) and healthy organs (organs at risk) and, thus, require a patient specific dose assessment. These calculations would help to optimize the amount of radioactivity to be administered and to reduce the risk of under- or over-dosing patients, otherwise observed when using empirical approaches to activity determination. As part of the selection, candidates will be requested to undertake a written test.

The workshop is under the umbrella of ICTP and IAEA and is expected to strengthen the knowledge of clinically qualified medical physicists working in nuclear medicine. The expected audience are clinically qualified medical physicists working in a hospital, with at least 5 years’ experience in the field of nuclear medicine medical physics including radionuclide therapy.